Steprise Pharmaceuticals Private Limited
About Steprise Pharmaceuticals Private Limited
Data last updated:
Steprise Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 02 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2019PTC232718. Its GSTIN is 19ABCCS2974F1Z4 (West Bengal).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Vikash Kr Singh and Sumit Pandey.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Bl – B; 1st – Fr; Fl – 2/F 12/A N C Mitra Road, Kolkata, West Bengal, India – 700028.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.98 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹55,664 (net margin -28.1%) and EBITDA of -₹47,996 (EBITDA margin -24.2%).
Company details
Contact details
Steprise Pharmaceuticals Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.
- Email
- Registered AddressBl – B; 1st – Fr; Fl – 2/F 12/A N C Mitra Road, Kolkata, West Bengal, India – 700028
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Steprise Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Steprise Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Steprise Pharmaceuticals Private Limited, buy the company report.
Financials of Steprise Pharmaceuticals Private Limited
FY 2023 filings availableSteprise Pharmaceuticals Private Limited reported revenue of ₹1.98 Lakh (up 9% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year. EBITDA rose 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹47,996 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹55,664 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -24.2% | |||
| Net Profit Margin | -28.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Steprise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Steprise Pharmaceuticals Private Limited
Steprise Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikash Kr Singh Also directs: Steprise Technology Private Limited | Director | 02 Jul 2019 | 7 Years 4 Months | Current |
| Sumit Pandey | Director | 02 Jul 2019 | 7 Years 4 Months | Current |
Legal cases
No court or tribunal cases involving Steprise Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Steprise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Steprise Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19ABCCS2974F1Z4 | West Bengal | Active | 31 Jan 2021 |
To see the full GST registrations and return filing status of Steprise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Steprise Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Sumit Pandey was appointed as Director on 02 Jul 2019.
Frequently asked questions
Steprise Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 02 July 2019 (7+ years old) and is registered under CIN U24239WB2019PTC232718.
Steprise Pharmaceuticals has 2 current directors:
- Vikash Kr Singh - Director
- Sumit Pandey - Director
The latest financial statements of Steprise Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Steprise Pharmaceuticals is 19ABCCS2974F1Z4, registered in West Bengal.
The CIN (Corporate Identification Number) of Steprise Pharmaceuticals is U24239WB2019PTC232718. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Steprise Pharmaceuticals was incorporated on 02 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Kolkata.
Sumit Pandey was appointed as Director on 02 Jul 2019. Vikash Kr Singh was appointed as Director on 02 Jul 2019.
The registered office of Steprise Pharmaceuticals is at Bl – B; 1st – Fr; Fl – 2F 12A N C Mitra Road, Kolkata, West Bengal, India – 700028.
Steprise Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Steprise Pharmaceuticals can be reached at its registered office: Bl – B; 1st – Fr; Fl – 2F 12A N C Mitra Road, Kolkata, West Bengal, India – 700028.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
